» Articles » PMID: 30354782

Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women

Abstract

Background: The value of vascular closure devices (VCD) in women undergoing transfemoral catheterization has not been sufficiently investigated.

Methods And Results: This is a sex-specific analysis of 1395 women enrolled in a large-scale, randomized, multicenter trial, in which patients undergoing transfemoral diagnostic coronary angiography were randomly assigned in a 1:1:1 ratio to arteriotomy closure with an intravascular VCD, extravascular VCD, or manual compression (MC). Primary objective was to assess the safety and efficacy of 2 different VCD compared with MC regarding vascular access-site complications at 30 days. A secondary comparison was between 2 different types of contemporary VCD. Overall, women were at higher risk for vascular access-site complications compared with men (9.0% versus 6.4%; P=0.002). Vascular access-site complications were comparable in women assigned to VCD and MC (8.6% versus 9.8%; P=0.451). There was no interaction of treatment effect and sex ( P=0.970). Time to hemostasis was significantly shortened with VCD compared with MC (1 [interquartile range, 0.5-2.0] minutes) versus 11 [interquartile range, 10-15] minutes; P<0.001); however, more women with VCD required repeat MC (2.4% versus 0.6%; P=0.018). The use of the intravascular compared with the extravascular VCD was associated with a numerical reduction in vascular access-site complications (6.6% versus 10.7%; P=0.027) and significant reductions in time to hemostasis and VCD failure.

Conclusions: In women undergoing diagnostic coronary angiography via the common femoral artery, VCD and MC provided comparable safety, while time to hemostasis was reduced with VCD.

Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01389375.

Citing Articles

FEMOSEAL CLOSE: multi-centre observational study with FemoSeal™ vascular closure device following peripheral percutaneous endovascular procedures.

Goueffic Y, Deloose K, Dubosq M, Zeller T CVIR Endovasc. 2025; 8(1):15.

PMID: 39985734 PMC: 11846783. DOI: 10.1186/s42155-025-00522-5.


Impact of Sex on Outcomes With Femoral Artery Closure Devices Versus Manual Compression in Patients Undergoing Percutaneous Coronary Intervention.

Anderson W, Torabi A, Oleary B, Breall J, Sinha A, Jaradat Z Health Sci Rep. 2024; 7(12):e70256.

PMID: 39703497 PMC: 11656100. DOI: 10.1002/hsr2.70256.


Sex Difference in 5-year Relative Survival Following Percutaneous Coronary Intervention.

Choi J, Choi J, Choi K, Lee J, Park T, Yang J Eur Cardiol. 2024; 19:e18.

PMID: 39449722 PMC: 11499972. DOI: 10.15420/ecr.2024.25.


Advancements in Vascular Closure Devices for Effective Hemostasis in Femoral Artery Interventions.

Ding W, Luo Y, Li W Med Sci Monit. 2024; 30:e944884.

PMID: 39439111 PMC: 11515585. DOI: 10.12659/MSM.944884.


SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization.

Lansky A, Baron S, Grines C, Tremmel J, Al-Lamee R, Angiolillo D J Soc Cardiovasc Angiogr Interv. 2024; 1(2):100016.

PMID: 39132570 PMC: 11307953. DOI: 10.1016/j.jscai.2021.100016.